Expand ANIX Menu
ANIX MENU

ANIX Latest Press Releases

-- March 12, 2026 --

Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast PRNewswire 10:39 AM

-- March 9, 2026 --

Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology PRNewswire 8:30 AM

-- March 2, 2026 --

Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress PRNewswire 9:10 AM

-- February 23, 2026 --

Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat PRNewswire 8:55 AM

-- February 9, 2026 --

Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation PRNewswire 8:00 AM

-- February 2, 2026 --

Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization PRNewswire 9:00 AM

-- January 27, 2026 --

Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology PRNewswire 8:30 AM

-- December 15, 2025 --

Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic PRNewswire 8:45 AM

-- December 11, 2025 --

Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants PRNewswire 6:02 PM

-- December 10, 2025 --

Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025 PRNewswire 9:00 AM

-- November 17, 2025 --

Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization PRNewswire 8:15 AM

-- November 12, 2025 --

Water Tower Research Issues Statement Regarding Technical Interruption During Anixa Biosciences Fireside Chat Globe Newswire 11:00 AM
Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s PRNewswire 9:00 AM

-- November 10, 2025 --

Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025 PRNewswire 10:30 AM

-- November 5, 2025 --

Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic PRNewswire 8:55 AM

-- October 23, 2025 --

Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference PRNewswire 8:47 AM

-- October 20, 2025 --

Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology PRNewswire 8:25 AM
Market Data Delayed 15 Minutes